Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
PRICE T ROWE ASSOCIATES INC | 6,535,368 5.400% |
2,859,543 (+77.79%) |
Filing History |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
The Vanguard Group | 10,702,771 8.950% |
176,347 (+1.68%) |
Filing History |
| 2022-02-09 09:09 am Purchase |
2022-02-08 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
FMR CORP | 17,940,020 14.999% |
1,848,075 (+11.48%) |
Filing History |
| 2022-02-04 09:12 am Sale |
2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
WELLINGTON MANAGEMENT CO LLP | 6,839,821 5.720% |
-3,217,119 (-31.99%) |
Filing History |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BLACKROCK INC BLK |
7,671,402 6.400% |
-1,052,318 (-12.06%) |
Filing History |
| 2022-01-18 07:06 am Purchase |
2021-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BAILLIE GIFFORD & CO | 10,616,751 8.880% |
1,484,329 (+16.25%) |
Filing History |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
The Vanguard Group | 10,526,424 9.060% |
238,952 (+2.32%) |
Filing History |
| 2021-02-08 10:15 am Sale |
2021-02-05 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
FMR CORP | 16,091,945 13.850% |
-628,430 (-3.76%) |
Filing History |
| 2021-02-03 1:33 pm Sale |
2020-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
WELLINGTON MANAGEMENT CO LLP | 10,056,940 8.660% |
-4,229,534 (-29.61%) |
Filing History |
| 2021-02-01 10:12 am Purchase |
2020-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BAILLIE GIFFORD & CO | 9,132,422 7.860% |
945,699 (+11.55%) |
Filing History |
| 2021-01-28 5:56 pm Purchase |
2020-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BLACKROCK INC BLK |
8,723,720 7.500% |
690,464 (+8.60%) |
Filing History |
| 2021-01-14 11:57 am Purchase |
2020-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BAILLIE GIFFORD & CO LTD | 9,132,422 7.860% |
9,132,422 (New Position) |
Filing History |